Aigen Investment Management’s RxSight RXST Stock Holding History

Aigen Investment Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.9K	Buy	+12,848	New	+$77.6K	0.02%	500
2025 Q1	–	Sell	-11,849	Closed	-$407K	–	996
2024 Q4	$407K	Buy	+11,849	New	+$534K	0.07%	390
2024 Q3	–	Sell	-3,820	Closed	-$230K	–	975
2024 Q2	$230K	Sell	3,820 -4,962	-57%	-$284K	0.04%	587
2024 Q1	$453K	Sell	8,782 -479	-5%	-$23.5K	0.1%	306
2023 Q4	$373K	Sell	9,261 -10,837	-54%	-$318K	0.07%	421
2023 Q3	$561K	Buy	+20,098	New	+$599K	0.11%	315

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aigen Investment Management's RXST Position: Q2 2026 in Review

Aigen Investment Management opened a new position in RxSight (RXST) in Q2 2026: 12,848 shares worth $61.9K. The stake represents 0.02% of the portfolio and ranks #500 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in RXST as recently as Q4 2024.

Aigen Investment Management first reported a position in RXST in Q3 2023 and has held it in 6 quarters since. The position peaked at $561K in Q3 2023. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Aigen Investment Management held 12,848 shares of RxSight worth $61.9K as of Q2 2026.
RxSight was a new Aigen Investment Management position in Q2 2026.
RxSight made up 0.02% of Aigen Investment Management's portfolio in Q2 2026, its #500 holding.
Aigen Investment Management first reported a position in RxSight in Q3 2023 and has held it in 6 quarters since.
Aigen Investment Management's RxSight position peaked at $561K in Q3 2023.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.